Abstract

    Open Access Perspective Study Article ID: IJCEM-7-153

    Vildagliptin-Metformin: Is it a causative of cardiac muscle failure in Type 2 Diabetic patients?

    YRKM Sai*

    Vildagliptin is an oral anti-hyperglycaemic agent, commonly called an anti-diabetic medication that belongs to the family of medications known as Dipeptidyl Peptidase-4 (DPP-4) inhibitors. It is a medicine that is used to treat Type 2 Diabetes Mellitus [1]. 

    Keywords:

    Published on: Sep 24, 2021 Pages: 1-2

    Full Text PDF Full Text HTML DOI: 10.17352/ijcem.000053
    CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat

    Indexing/Archiving

    Pinterest on IJCEM